Buying Adaptimmune Therapeutics plc (ADAP) Stock Is A Smart Move Today?
Adaptimmune Therapeutics plc (NASDAQ:ADAP) finished Thursday with a subtraction of -$0.02 to close at $0.78, a downside of -2.25 percent. An average of 438,602 shares of common stock have been traded in the last five days. There was a fall of -$0.0052 in the past week, and it reached a new high 4 times over […]
Take A Look At Insider Trading For Adaptimmune Therapeutics plc (ADAP)
The stock of Adaptimmune Therapeutics plc (NASDAQ:ADAP) decreased by $0.0 on Friday to finish at $0.81, down -0.61 percent. The last five days have seen an average of 700,320 shares of common stock traded. 4 times new highs were reached in the current year, with a fall of -$0.6500. The average number of shares traded […]
